Cited by 501Antibiotic Use and ResistanceAntibiotic Resistance in BacteriaPharmaceutical Economics and Policy

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

Klein, Eili Y, Milkowska-Shibata, Maja, Tseng, Katie K, Sharland, Mike, Gandra, Sumanth, Pulcini, Céline, Laxminarayan, Ramanan·2021·The Lancet Infectious Diseases

DOI 10.1016/s1473-3099(20)30332-7

Open this paper in CoChat — free account

Abstract

Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework aims to balance appropriate access to antibiotics and stewardship. We aimed to identify how patterns of antibiotic consumption in each of the AWaRe categories changed across countries over 15 years. Methods Antibiotic consumption was classified into Access, Watch, and Reserve categories for 76 countries between 2000, and 2015, using quarterly national sample survey data obtained from IQVIA. We measured the proportion of antibiotic use in each category, and calculated the ratio of Access antibiotics to Watch antibiotics (access-to-watch index), for each country. Findings Between 2000, and 2015, global per-capita consumption of Watch antibiotics increased by 90·9% (from 3·3 to 6·3 defined daily doses per 1000 inhabitants per day [DIDs]) compared with an increase of 26·2% (from 8·4 to 10·6 DIDs) in Access antibiotics. The increase in Watch antibiotic consumption was greater in low-income and middle-income countries (LMICs; 165·0%; from 2·0 to 5·3 DIDs) than in high-income countries (HICs; 27·9%; from 6·1 to 7·8 DIDs). The access-to-watch index decreased by 38·5% over the study period globally (from 2·6 to 1·6); 46·7% decrease in LMICs (from 3·0 to 1·6) and 16·7% decrease in HICs (from 1·8 to 1·5), and 37 (90%) of 41 LMICs had a decrease in their relative access-to-watch consumption. The proportion of countries in which Access antibiotics represented at least 60% of their total antibiotic consumption (the WHO national-level target) decreased from 50 (76%) of 66 countries in 2000, to 42 (55%) of 76 countries in 2015. Interpretation Rapid increases in Watch antibiotic consumption, particularly in LMICs, reflect challenges in antibiotic stewardship. Without policy changes, the WHO national-level target of at least 60% of total antibiotic consumption being in the Access category by 2023, will be difficult to achieve. The AWaRe framework is an important measure of the effort to combat antimicrobial resistance and to ensure equal access to effective antibiotics between countries. Funding US Centers for Disease Control and Prevention.

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(20)30332-7

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Self-citation
The threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 476
Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries
Hsia, Y., Lee, B. R., Versporten, A., Yang, Y., Bielicki, J. A., Jackson, C., Newland, J. G., Goossens, H., Magrini, N., Sharland, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30071-3 · Cited by 350
Self-citation
Antibiotic use in eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe
Versporten, A., Bolokhovets, G., Ghazaryan, L., Abilova, V., Pyshnik, G., Spasojevic, T., Korinteli, I., Raka, L., Kambaralieva, B., Čizmović, L., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70071-4 · Cited by 290
Comparison of Outpatient Systemic Antibacterial Use in 2004 in the United States and 27 European Countries
Goossens, H., Ferech, M., Coenen, S., Stephens, P., & European Surveillance of Antimicrobial Consumption Project Group (2007) · Clinical Infectious Diseases · doi:10.1086/512810 · Cited by 226
Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries
Hsia, Y., Sharland, M., Jackson, C., Wong, I. C. K., Magrini, N., & Bielicki, J. A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30547-4 · Cited by 206
Self-citation
Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
Mendelson, M., Røttingen, J., Gopinathan, U., Hamer, D. H., Wertheim, H. F. L., Basnyat, B., Butler, C., Tomson, G. B., & Balasegaram, M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00547-4 · Cited by 205
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
Klein, E. Y., Tseng, K. K., Pant, S., & Laxminarayan, R. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001315 · Cited by 178
Self-citation
Opportunities and barriers to implementing antibiotic stewardship in low and middle-income countries: Lessons from a mixed-methods study in a tertiary care hospital in Ethiopia
Gebretekle, G. B., Mariam, D. H., Abebe, W., Amogne, W., Tenna, A., Fenta, T. G., Libman, M., Yansouni, C. P., & Semret, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208447 · Cited by 133

Show all 26 references

Sorted by citations

Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study
Browne, A. J., Chipeta, M. G., Haines-Woodhouse, G., Kumaran, E. P. A., Hamadani, B. H. K., Zaraa, S., Henry, N. J., Deshpande, A., Reiner, R. C., Day, N. P. J., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(21)00280-1 · Cited by 865
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H., Ando, M., Song, M., Tamimi, R. M., Kawachi, I. I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 652
Global trends in antibiotic consumption during 2016–2023 and future projections through 2030
Klein, E. Y., Impalli, I., Poleon, S., Denoël, P., Cipriano, M., Boeckel, T. P. V., Pecetta, S., Bloom, D. E., & Nandi, A. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411919121 · Cited by 481
Self-citation
The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance
Zanichelli, V., Sharland, M., Cappello, B., Moja, L., Getahun, H., Pessoa-Silva, C. L., Sati, H. F., Weezenbeek, C. V., Balkhy, H. H., Simão, M. B. G., et al. (2023) · Bulletin of the World Health Organization · doi:10.2471/blt.22.288614 · Cited by 296
Self-citation
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Godman, B., Egwuenu, A. J., Haque, M., Malande, O. O., Schellack, N., Kumar, S., Saleem, Z., Sneddon, J., Hoxha, I., Islam, S., et al. (2021) · Life · doi:10.3390/life11060528 · Cited by 244
Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022
Nandi, A., Pecetta, S., & Bloom, D. E. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.101848 · Cited by 238
Antimicrobial Transformation Products in the Aquatic Environment: Global Occurrence, Ecotoxicological Risks, and Potential of Antibiotic Resistance
Löffler, P., Escher, B. I., Baduel, C., Virta, M., & Lai, F. Y. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.2c09854 · Cited by 234
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis
Lewnard, J. A., Charani, E., Gleason, A., Hsu, L. Y., Khan, W. A., Karkey, A., Chandler, C. I. R., Mashe, T., Khan, E. A., Bulabula, A. N. H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00862-6 · Cited by 220
Self-citation
Occurrence and spatial distribution of pharmaceuticals and personal care products (PPCPs) in the aquatic environment, their characteristics, and adopted legislations
Hawash, H. B. I., Moneer, A. A., Galhoum, A. A., Elgarahy, A. M., Mohamed, W. A. A., Samy, M., El-Seedi, H. R., Gaballah, M. S., Mubarak, M. F., & Attia, N. F. (2023) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2023.103490 · Cited by 233
Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally
Ya, K. Z., Win, P. T. N., Bielicki, J. A., Lambiris, M. J., & Fink, G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.53806 · Cited by 233
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis
Ayobami, O., Brinkwirth, S., Eckmanns, T., & Markwart, R. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2030196 · Cited by 210
Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis
Sulis, G., Sayood, S. J., Katukoori, S., Bollam, N., George, I. A., Yaeger, L., Chavez, M. A., Tetteh, E. K., Yarrabelli, S., Pulcini, C., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.03.014 · Cited by 176
Self-citation
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries
Pauwels, I., Versporten, A., Drapier, N., Vlieghe, E., Goossens, H., the Global-PPS network, Koraqi, A., Hoxha, I., Tafaj, S., Cornistein, W., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab050 · Cited by 175
Antibiotics and antibiotic resistance genes in landfills: A review
Zhang, R., Yang, S., An, Y., Wang, Y., Yu, L., & Song, L. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150647 · Cited by 171
Antibiotics in global rivers
Li, S., Liu, Y., Yang, W., Hu, J., Zhang, Y., Sun, Q. Y., Sun, W., Geng, J., Liu, X., Jia, D., et al. (2022) · National Science Open · doi:10.1360/nso/20220029 · Cited by 165
Global consumption of prescription opioid analgesics between 2009-2019: a country-level observational study
Jayawardana, S., Forman, R., Johnston-Webber, C., Campbell, A., Berterame, S., de Joncheere, C., Aitken, M. L., & Mossialos, E. A. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101198 · Cited by 172
Ciprofloxacin removal from non-clinical environment: A critical review of current methods and future trend prospects
Al-Buriahi, A. K., Al-shaibani, M. M., Mohamed, R. M. S. R., Al-Gheethi, A. A. S., Sharma, A. K., & Ismail, N. (2022) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2022.102725 · Cited by 152
Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
Godman, B., Egwuenu, A. J., Wesangula, E., Schellack, N., Kalungia, A. C., Tiroyakgosi, C., Kgatlwane, J., Mwita, J. C., Okwen, P., Niba, L. L., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2106368 · Cited by 151
Global increases in antibiotic consumption: a concerning trend for WHO targets
Roberts, S. C., & Zembower, T. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30456-4 · Cited by 142
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Moja, L., Zanichelli, V., Mertz, D., Gandra, S., Cappello, B., Cooke, G., Chuki, P., Harbarth, S., Pulcini, C., Mendelson, M., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.003 · Cited by 158
Self-citation
Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya
Sulis, G., Daniels, B., Kwan, A., Gandra, S., Daftary, A., Das, J., & Pai, M. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003393 · Cited by 132
Self-citation
The WHO essential medicines list AWaRe book: from a list to a quality improvement system
Sharland, M., Zanichelli, V., Ombajo, L. A., Bazira, J., Cappello, B., Chitatanga, R., Chuki, P., Gandra, S., Getahun, H., Harbarth, S., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.08.009 · Cited by 133
Self-citation
Menace of antimicrobial resistance in LMICs: Current surveillance practices and control measures to tackle hostility
Sharma, A., Singh, A., Dar, M. A., Kaur, R. J., Charan, J., Iskandar, K., Haque, M., Murti, K., Ravichandiran, V., & Dhingra, S. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.008 · Cited by 120
Ensuring progress on sustainable access to effective antibiotics at the 2024 UN General Assembly: a target-based approach
Mendelson, M., Lewnard, J. A., Sharland, M., Cook, A., Pouwels, K. B., Alimi, Y. H., Mpundu, M. M., Wesangula, E., Weese, J. S., Røttingen, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01019-5 · Cited by 113
Self-citation
Optimising antimicrobial use in humans – review of current evidence and an interdisciplinary consensus on key priorities for research
Charani, E., McKee, M., Ahmad, R., Balasegaram, M., Bonaconsa, C., Buckland‐Merrett, G., Busse, R., Carter, V., Castro‐Sánchez, E., Franklin, B. D., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100161 · Cited by 114
Antimicrobial Peptides and Small Molecules Targeting the Cell Membrane of Staphylococcus aureus
Ganesan, N., Mishra, B., LewisOscar, F., & Mylonakis, E. E. (2023) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00037-22 · Cited by 112
Consumption of systemic antibiotics in India in 2019
Koya, S. F., Ganesh, S., Selvaraj, S., Wirtz, V. J., Galea, S., & Rockers, P. C. (2022) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2022.100025 · Cited by 102
Virus-Induced Changes of the Respiratory Tract Environment Promote Secondary Infections With Streptococcus pneumoniae
Sender, V., Hentrich, K., & Henriques‐Normark, B. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.643326 · Cited by 98
Emerging 2D MXenes for antibacterial applications: Current status, challenges, and prospects
He, X., Koo, S., Obeng, E., Sharma, A. K., Shen, J., & Kim, J. S. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215275 · Cited by 96
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
Sono, T. M., Yeika, E., Cook, A., Kalungia, A., Opanga, S. A., Acolatse, J. E. E., Sefah, I. A., Jelić, A. G., Campbell, S., Lorenzetti, G., et al. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2259106 · Cited by 95
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Saleem, Z., Godman, B., Cook, A., Khan, M. A., Campbell, S., Seaton, R. A., Siachalinga, L., Haseeb, A., Amir, A., Kurdi, A. B., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11121824 · Cited by 97
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications
Saleem, Z., Godman, B., Azhar, F., Kalungia, A. C., Fadare, J. O., Opanga, S. A., Marković‐Peković, V., Hoxha, I., Saeed, A., Algethamy, M., et al. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1935238 · Cited by 92
A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective, multicentre cohort study
Papan, C., Argentiero, A., Porwoll, M., Hakim, U., Farinelli, E., Testa, I., Pasticci, M. B., Mezzetti, D., Perruccio, K., Etshtein, L., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.019 · Cited by 95
Hospital Wastewater—Source of Specific Micropollutants, Antibiotic-Resistant Microorganisms, Viruses, and Their Elimination
Mackuľak, T., Cverenkárová, K., Staňová, A. V., Fehér, M., Tamáš, M., Škulcová, A., Gál, M., Naumowicz, M., Špalková, V., & Bírošová, L. (2021) · Antibiotics · doi:10.3390/antibiotics10091070 · Cited by 92
Profiling of the spatiotemporal distribution, risks, and prioritization of antibiotics in the waters of Laizhou Bay, northern China
Lü, S., Lin, C., Lei, K., Xin, M., Gu, X., Lian, M., Wang, B., Liu, X., Ouyang, W., & He, M. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.127487 · Cited by 86
Occurrence of antibiotics in wastewater: Potential ecological risk and removal through anaerobic–aerobic systems
Mishra, S., Singh, A. K., Liu, C., Hussain, A., & Maiti, A. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115678 · Cited by 86
Exacerbated anthropogenic water pollution under climate change and urbanization
Yang, W., Schmidt, C., Wu, S., Zhao, Z., Li, R., Wang, Z., Wang, H., Hua, P., Krebs, P., & Zhang, J. (2025) · Water Research · doi:10.1016/j.watres.2025.123449 · Cited by 86
Advancing global antibiotic research, development and access
Piddock, L. J. V., Alimi, Y. H., Anderson, J., de Felice, D., Moore, C. E., Røttingen, J., Skinner, H., & Beyer, P. (2024) · Nature Medicine · doi:10.1038/s41591-024-03218-w · Cited by 92
Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
Zabala, G. A., Bellingham, K., Vidhamaly, V., Boupha, P., Boutsamay, K., Newton, P. N., & Caillet, C. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008587 · Cited by 83
Significantly Enhanced Electrocatalytic Reduction of Chloramphenicol from Water Mediated by Fe–F–N Co-doped Carbon Materials
Jin, W., Feng, J., Xing, W., & Tang, W. (2023) · ACS ES&T Water · doi:10.1021/acsestwater.3c00059 · Cited by 83
A review of the recent advancements in adsorption technology for removing antibiotics from hospital wastewater
Nugraha, M. W., Kim, S., Roddick, F., Xie, Z., & Fan, L. (2025) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2025.106960 · Cited by 88
Antibiotics in the global river system arising from human consumption
Macedo, H. E., Lehner, B., Nicell, J. A., Khan, U., & Klein, E. Y. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf096 · Cited by 84
Self-citation
Fluorescence analysis of antibiotics and antibiotic-resistance genes in the environment: A mini review
Li, Y., Liu, C., Li, Q., & Mao, S. (2024) · Chinese Chemical Letters · doi:10.1016/j.cclet.2024.109541 · Cited by 79
Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications
Mwita, J. C., Ogunleye, O. O., Olalekan, A. O., Kalungia, A. C., Kurdi, A. B., Saleem, Z., Sneddon, J., & Godman, B. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s253216 · Cited by 80
Navigating sociocultural disparities in relation to infection and antibiotic resistance—the need for an intersectional approach
Charani, E., Mendelson, M., Ashiru-Oredope, D. A. I., Hutchinson, E., Kaur, M., McKee, M., Mpundu, M. M., Price, J. R., Shafiq, N., & Holmes, A. H. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab123 · Cited by 86
Comprehensive overview of antibiotic distribution, risk and priority: A study of large-scale drinking water sources from the lower Yangtze River
Wang, N., Wang, N., Qi, D., Kang, G., Wang, W., Zhang, C., Zhang, Z., Zhang, Y., Zhang, H., Zhang, Y., et al. (2023) · Journal of Environmental Management · doi:10.1016/j.jenvman.2023.118705 · Cited by 69
Metagenomic Insight into Microbiome and Antibiotic Resistance Genes of High Clinical Concern in Urban and Rural Hospital Wastewater of Northern India Origin: a Major Reservoir of Antimicrobial Resistance
Talat, A., Blake, K. S., Dantas, G. A., & Khan, A. U. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04102-22 · Cited by 73
Antibiotic resistance in the microbiota of periodontitis patients: an update of current findings
Ng, E., Tay, J. R. H., Boey, S. K., Laine, M. L., Ivanovski, S., & Seneviratne, C. J. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2197481 · Cited by 64
Climate warming, environmental degradation and pollution as drivers of antibiotic resistance
Rzymski, P., Gwenzi, W., Poniedziałek, B., Mangul, S., & Fal, A. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123649 · Cited by 68
Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications
Siachalinga, L., Godman, B., Mwita, J. C., Sefah, I. A., Ogunleye, O. O., Massele, A. Y., & Lee, I. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s398223 · Cited by 64
Meta-analysis addressing the characterization and risk identification of antibiotics and antibiotic resistance genes in global groundwater
Liu, C., Chen, J., Shan, X., Yang, Y., Song, L., Teng, Y., & Chen, H. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160513 · Cited by 62
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)
Khouja, T., Mitsantisuk, K., Tadrous, M., & Suda, K. J. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac028 · Cited by 59
Enhancing proline-rich antimicrobial peptide action by homodimerization: influence of bifunctional linker
Li, W., Lin, F. W., Hung, A., Barlow, A. J., Sani, M., Paolini, R. A., Singleton, W., Holden, J. A., Hossain, M. A., Separovic, F., et al. (2022) · Chemical Science · doi:10.1039/d1sc05662j · Cited by 57
Freshwater environment as a reservoir of extended-spectrum β-lactamase-producing Enterobacteriaceae
Cho, S., Jackson, C. R., & Frye, J. G. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad034 · Cited by 58
Optimizing antibiotic use in Indonesia: A systematic review and evidence synthesis to inform opportunities for intervention
Limato, R., Lazarus, G., Dernison, P., Mudia, M., Alamanda, M., Nelwan, E. J., Sinto, R., Karuniawati, A., van Doorn, H. R., & Hamers, R. L. (2022) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2022.05.002 · Cited by 79
RETRACTED: Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward
Alshammari, M. K., Ramadan, M., Haif, H., Abdullah, B., Mubarak, J., Ahmad, W., Mari, S., Hassan, S., Eid, R., Hasan, M. Y., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12101504 · Cited by 59
Retracted
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications
Skosana, P., Schellack, N., Godman, B., Kurdi, A. B., Bennie, M., Kruger, D., & Meyer, J. C. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1898946 · Cited by 54
Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries
Saleem, Z., Sheikh, S., Godman, B., Haseeb, A., Afzal, S., Qamar, M. U., Imam, M. T., Abuhussain, S. S. A., & Sharland, M. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf031 · Cited by 59
Self-citation
Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe
Robertson, J., Vlahović–Palčevski, V., Iwamoto, K., Högberg, L. D., Godman, B., Monnet, D. L., Garner, S. E., Weist, K., ESAC-Net Study Group, & WHO Europe AMC Network Study Group (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639207 · Cited by 52
Regulatory Risk Assessment of Pharmaceuticals in the Environment: Current Practice and Future Priorities
Oldenkamp, R., Hamers, T., Wilkinson, J. L., Slootweg, J., & Posthuma, L. (2022) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5535 · Cited by 51
Meta-Analysis for the Global Prevalence of Foodborne Pathogens Exhibiting Antibiotic Resistance and Biofilm Formation
Tao, Q., Wu, Q., Zhang, Z., Liu, J., Tian, C., Huang, Z., Malakar, P. K., Pan, Y., & Zhao, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.906490 · Cited by 56
Pattern of Antibiotic Dispensing at Pharmacies According to the WHO Access, Watch, Reserve (AWaRe) Classification in Bangladesh
Islam, M. A., Akhtar, Z., Hassan, M. Z., Chowdhury, S., Rashid, M. M., Aleem, M. A., Ghosh, P. K., Mah‐E‐Muneer, S., Parveen, S., Ahmmed, M. K., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020247 · Cited by 50
Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future
Sefah, I., Essah, D., Kurdi, A., Sneddon, J., Alalbila, T., Kordorwu, H., & Godman, B. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab080 · Cited by 44
Crossover-Use of Human Antibiotics in Livestock in Agricultural Communities: A Qualitative Cross-Country Comparison between Uganda, Tanzania and India
Myers, J., Hennessey, M., Arnold, J.-C., McCubbin, K. D., Lembo, T., Mateus, A., Kitutu, F. E., Samanta, I., Hutchinson, E., Davis, A., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101342 · Cited by 45
Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries
Saleem, Z., Moore, C. E., Kalungia, A. C., Schellack, N., Ogunleye, O. O., Chigome, A., Chowdhury, K., Kitutu, F. E., Massele, A. Y., Ramdas, N., et al. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf033 · Cited by 57
Self-citation
A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals
Limato, R., Nelwan, E. J., Mudia, M., de Brabander, J., Guterres, H., Enty, E., Mauleti, I. Y., Mayasari, M., Firmansyah, I., Hizrani, M., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab047 · Cited by 45
Using mystery shoppers to determine practices pertaining to antibiotic dispensing without a prescription among community pharmacies in South Africa—a pilot survey
Mokwele, R. N., Schellack, N., Bronkhorst, E., Brink, A. J., Schweickerdt, L., & Godman, B. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab196 · Cited by 48
Occurrence, removal, emission and environment risk of 32 antibiotics and metabolites in wastewater treatment plants in Wuhu, China
Zhang, L., Zhu, Z., Zhao, M., He, J., Zhang, X., Hao, F., & Du, P. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165681 · Cited by 43
Ongoing Strategies to Improve Antimicrobial Utilization in Hospitals across the Middle East and North Africa (MENA): Findings and Implications
Haseeb, A., Saleem, Z., Maqadmi, A. F., Allehyani, R. A., Mahrous, A. J., Elrggal, M. E., Kamran, S. H., Algethamy, M., Naji, A. S., AlQarni, A., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12050827 · Cited by 46
Remediation of tetracycline pollution using microplastics, green materials, membranes and sonocatalysts: a review
Sivanesan, J., Sivaprakash, B., Rajamohan, N., Phanindra, V. S. S., Sonne, C., Liew, R. K., & Lam, S. S. (2024) · Environmental Chemistry Letters · doi:10.1007/s10311-024-01777-5 · Cited by 43
Nudge interventions to reduce unnecessary antibiotic prescribing in primary care: a systematic review
Raban, M. Z., Gonzalez, G., Nguyen, A., Newell, B. R., Li, L., Seaman, K. L., & Westbrook, J. I. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-062688 · Cited by 41
Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Sisay, M., Amare, F., Hagos, B., & Edessa, D. (2021) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-021-00339-2 · Cited by 40
Global antibiotic consumption and regional antimicrobial resistance, 2010–21: an analysis of pharmaceutical sales and antimicrobial resistance surveillance data
Wang, L., Chen, H., Zhang, Y., Tian, Y., Hu, X., Wu, J., Li, X., Jia, H., Wang, H., Yu, C., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(25)00308-0 · Cited by 40
Antibiotic Resistome and its Driving Factors in an Urban River in Northern China
Wu, Y., Qi, D., Hong, Y., Ren, J., Hu, J., Lyu, Y., Yang, S., & Sun, W. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156536 · Cited by 40
Antibiotic Use and Stewardship Indicators in the First- and Second-Level Hospitals in Zambia: Findings and Implications for the Future
Kalungia, A. C., Mukosha, M., Mwila, C., Banda, D., Mwale, M., Kagulura, S. S., Ogunleye, O. O., Meyer, J. C., & Godman, B. (2022) · Antibiotics · doi:10.3390/antibiotics11111626 · Cited by 40
A point-of-need platform for rapid measurement of a host-protein score that differentiates bacterial from viral infection: Analytical evaluation
Hainrichson, M., Avni, N., Eden, E., Feigin, P. D., Gelman, A., Halabi, S., Hartog-David, E., Hultén, K. G., Ashkar, J., Kalfon, R., et al. (2022) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2022.04.012 · Cited by 39
A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance
Chigome, A., Ramdas, N., Skosana, P., Cook, A., Schellack, N., Campbell, S., Lorenzetti, G., Saleem, Z., Godman, B., & Meyer, J. C. (2023) · Antibiotics · doi:10.3390/antibiotics12101540 · Cited by 44
An LC-MS/MS method for the simultaneous determination of 18 antibacterial drugs in human plasma and its application in therapeutic drug monitoring
Lu, W., Pan, M., Ke, H., Liang, J. S., Liang, W., Yu, P., Zhang, P., & Wang, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1044234 · Cited by 40
Highly Sensitive Ratiometric Fluorescent Flexible Sensor Based on the RhB@ZIF-8@PVDF Mixed-Matrix Membrane for Broad-Spectrum Antibiotic Detection
Xu, N., Tang, Z., Jiang, Y., Fang, J., Zhang, L., Lai, X., Sun, Q., Fan, J., Tang, X., Liu, Q., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12756 · Cited by 37
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications
Saleem, Z., Mekonnen, B. A., Orubu, E. S. F., Islam, M. A., Phuong, T. N. T., Ubaka, C. M., Buma, D. C., Do, N. T. T., Sant, Y., Sono, T. M., et al. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2477198 · Cited by 45
Self-citation
Synergistic catalytic degradation of ciprofloxacin using magnetic carbon nanomaterial/NiFe2O4 promoted cold atmospheric pressure plasma jet: Influence of charcoal, multi walled carbon nanotubes and walnut shell
Sar, A. B., Shabani, E. G., Haghighi, M., & Shabani, M. (2021) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2021.10.031 · Cited by 37
Impact of eight widely consumed antibiotics on the growth and physiological profile of natural soil microbial communities
Pino-Otín, M. R., Ferrando, N., Ballestero, D., Langa, E., Roig, F. J., & Terrado, E. M. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135473 · Cited by 37
Educational Activities for Students and Citizens Supporting the One-Health Approach on Antimicrobial Resistance
Marvasi, M., Casillas-Martínez, L., Vassallo, A., & Purchase, D. (2021) · Antibiotics · doi:10.3390/antibiotics10121519 · Cited by 36
Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study
Hussein, R. R. S., Rabie, A. S. I., Shaman, M. B., Shaaban, A. H., Fahmy, A. M., Sofy, M. R., Lattyak, E. A., Abuelhana, A., Naguib, I. A., Ashour, A. M., et al. (2022) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17148 · Cited by 36
Rainfall leads to elevated levels of antibiotic resistance genes within seawater at an Australian beach
Williams, N. L. R., Siboni, N., McLellan, S. L., Potts, J., Scanes, P., Johnson, C., James, M., McCann, V., & Seymour, J. R. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2022.119456 · Cited by 35
Community drug retail outlet staff’s knowledge, attitudes and practices towards non-prescription antibiotics use and antibiotic resistance in the Amhara region, Ethiopia with a focus on non-urban towns
Belachew, S. A., Hall, L., & Selvey, L. A. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01102-1 · Cited by 35
Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications
Ramzan, K., Shafiq, S., Raees, I., Mustafa, Z. U., Salman, M., Khan, A. H., Meyer, J. C., & Godman, B. (2022) · Antibiotics · doi:10.3390/antibiotics11060789 · Cited by 34
Ag and CuO nanoparticles decorated on graphene oxide/activated carbon as a novel adsorbent for the removal of cephalexin from water
Wernke, G., Silva, M. F., da Silva, E. A., Fagundes‐Klen, M. R., Suzaki, P. Y. R., Triques, C. C., & Bergamasco, R. (2021) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2021.127203 · Cited by 34
Greenhouse gas impact from medical emissions of halogenated anaesthetic agents: a sales-based estimate
Talbot, A., Holländer, H. C., & Bentzer, P. (2025) · The Lancet Planetary Health · doi:10.1016/s2542-5196(25)00027-0 · Cited by 33
Integrating advanced techniques and machine learning for landfill leachate treatment: Addressing limitations and environmental concerns
Gaur, V. K., Gautam, K., Vishvakarma, R., Sharma, P., Pandey, U., Srivastava, J. K., Varjani, S., Chang, J., Ngo, H. H., & Wong, J. W. C. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124134 · Cited by 32
Irrigation of soil with reclaimed wastewater acts as a buffer of microbial taxonomic and functional biodiversity
Guedes, P. R., Martins, C., Couto, N., da Silva, J. R., Mateus, E. P., Ribeiro, A. B., & Pereira, C. S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.149671 · Cited by 32
Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso
Valia, D., Ingelbeen, B., Kaboré, B., Karama, I., Peeters, M., Lompo, P., Vlieghe, E., Post, A. S., Cox, J., de Mast, Q., et al. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01098-8 · Cited by 31
Hospital prescribing patterns of antibiotics in Zambia using the WHO prescribing indicators post-COVID-19 pandemic: findings and implications
Mudenda, S., Chilimboyi, R., Matafwali, S. K., Daka, V., Mfune, R. L., Kemgne, L. A. M., Bumbangi, F. N., Hangoma, J. M., Chabalenge, B., Mweetwa, L. L., et al. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae023 · Cited by 33
Fenton-like process in antibiotic-containing wastewater treatment: Applications and toxicity evaluation
Yang, J., Wang, S., Luo, X., Yu, Z., & Zhou, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.110996 · Cited by 31
Antibiotics in wastewater treatment plants and receiving waterbodies: Occurrence, Removal and Risks
Bekele, R. S., Heiderscheidt, E., Rossi, P. M., Moges, M. E., & Janka, E. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127702 · Cited by 29
Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study
Guma, S., Godman, B., Campbell, S., & Mahomed, O. H. (2022) · Antibiotics · doi:10.3390/antibiotics11101423 · Cited by 31
Is there a role for antibiotics in the treatment of chronic rhinosinusitis?
Smith, S. S., Kim, R., & Douglas, R. G. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.02.004 · Cited by 33
Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana
Otieku, E., Fenny, A. P., Labi, A.-K., Ofori, A. O., Kurtzhals, J. A. L., & Enemark, U. (2023) · PharmacoEconomics - Open · doi:10.1007/s41669-022-00385-9 · Cited by 28
Progress towards antibiotic use targets in eight high-income countries
Simmons, B., Ariyoshi, K., Ohmagari, N., Pulcini, C., Huttner, B. D., Gandra, S., Satta, G., Moja, L., Sharland, M., Magrini, N., et al. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.270934 · Cited by 28
Self-citation
Microplastics accumulation in mangroves increasing the resistance of its colonization Vibrio and Shewanella
Tan, B., Li, Y., Xie, H., Dai, Z., Zhou, C., Qian, Z., Hong, P., Liang, Y., Ren, L., Sun, S., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.133861 · Cited by 28

Authors: Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R.
Affiliations: Center for Disease Dynamics, Economics & Policy (US)
St George's, University of London (GB)
Washington University in St. Louis (US)
Corresponding author: Klein, Eili Y
ORCID: Klein, Eili Y
Tseng, Katie K
Sharland, Mike
Gandra, Sumanth
Laxminarayan, Ramanan
Venue: The Lancet Infectious Diseases
Publisher: Elsevier BV
Published: 2021-01
Volume: 21
Issue: 1
Pages: 107-115
ISSN: 1473-3099 (ISSN-L)
DOI: 10.1016/s1473-3099(20)30332-7
OpenAlex: W3044776476
Cited by: 500
References: 26
Citations by year: 2026: 61 · 2025: 95 · 2024: 110 · 2023: 94 · 2022: 78 · 2021: 58
FWCI: 34.82
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
St George's Online Research Archive (St George's University of London) (acceptedVersion)
HAL (submittedVersion)
Funders: Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords: antibiotic use, AWaRe classification, antibiotic access, antibiotic stewardship, pharmaceutical sales data, Watch antibiotics, low- and middle-income countries, high-income countries, defined daily doses, antimicrobial resistance, cross-national comparison
MeSH terms: Antimicrobial Stewardship, Anti-Bacterial Agents, Commerce, Developing Countries, Drug Utilization, Pharmaceutical Preparations, Forecasting, Humans, World Health Organization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks